PMID- 10525450 OWN - NLM STAT- MEDLINE DCOM- 19991122 LR - 20071115 IS - 1046-2023 (Print) IS - 1046-2023 (Linking) VI - 19 IP - 1 DP - 1999 Sep TI - Dendritic cells as natural adjuvants. PG - 142-7 AB - Dendritic cells (DCs) are professional antigen presenting cells that hold the key to the induction of T-cell responses. Therefore, the use of DCs for immunotherapy to stimulate immune responses has recently raised a great deal of interest. Many clinical trials using DCs have been initiated to stimulate immune responses against tumors or infectious agents. Several issues need to be considered before DCs can be used successfully as natural adjuvants: DCs have to be generated in sufficient numbers; they should display morphological, phenotypical, and functional properties of DCs; and they should be able to present antigens. In the present review we focus on methods for the purification of DCs from human bone marrow and peripheral blood and for the optimization of in vitro cell culture systems. Methods to generate growth factor-dependent mouse DC lines are also described. CI - Copyright 1999 Academic Press. FAU - Citterio, S AU - Citterio S AD - Department of Biotechnology and Biological Sciences, University of Milano-Bicocca, Milan, I-20129, Italy. FAU - Rescigno, M AU - Rescigno M FAU - Foti, M AU - Foti M FAU - Granucci, F AU - Granucci F FAU - Aggujaro, D AU - Aggujaro D FAU - Gasperi, C AU - Gasperi C FAU - Matyszak, M K AU - Matyszak MK FAU - Girolomoni, G AU - Girolomoni G FAU - Ricciardi-Castagnoli, P AU - Ricciardi-Castagnoli P LA - eng PT - Journal Article PT - Review PL - United States TA - Methods JT - Methods (San Diego, Calif.) JID - 9426302 RN - 0 (Adjuvants, Immunologic) RN - 0 (Growth Substances) SB - IM MH - *Adjuvants, Immunologic MH - Animals MH - Blood Cells/cytology/immunology MH - Bone Marrow Cells/cytology/immunology MH - Cell Line MH - Cell Separation/methods MH - Clinical Trials as Topic MH - Dendritic Cells/cytology/drug effects/*immunology MH - Growth Substances/administration & dosage MH - Humans MH - Immunotherapy/methods MH - Mice MH - Neoplasms/immunology/therapy RF - 41 EDAT- 1999/10/20 00:00 MHDA- 1999/10/20 00:01 CRDT- 1999/10/20 00:00 PHST- 1999/10/20 00:00 [pubmed] PHST- 1999/10/20 00:01 [medline] PHST- 1999/10/20 00:00 [entrez] AID - S1046-2023(99)90839-3 [pii] AID - 10.1006/meth.1999.0839 [doi] PST - ppublish SO - Methods. 1999 Sep;19(1):142-7. doi: 10.1006/meth.1999.0839.